
Luciole Medical
Measuring key oxygenation and flow parameters of the brain.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor investor | €0.0 | round | |
* | CHF5.3m | Series A | |
Total Funding | 000k |
USD | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Luciole Medical AG, based in Zurich, Switzerland, is a medical technology company specializing in brain monitoring equipment. The company focuses on providing reliable systems for measuring critical brain oxygenation and blood flow parameters, which are essential in detecting potentially serious health risks. Luciole Medical's products are particularly relevant in situations where oxygen supply and consumption are unknown, such as during coronary bypass surgery, where 25% of patients may suffer from long-term cognitive dysfunction due to decreased cerebral blood flow. The company operates in the medtech sector, serving healthcare providers and institutions that require advanced monitoring solutions for brain hemodynamics and oxygenation. Luciole Medical generates revenue through the sale and distribution of its specialized monitoring equipment. The company has also entered into research collaborations, such as with the Fondation Adolphe de Rothschild, to further advance brain metabolism monitoring research.
Keywords: brain oxygenation, blood flow measurement, medical technology, brain monitoring, healthcare, cognitive dysfunction, coronary bypass, hemodynamics, oxygen supply, Zurich.
Tech stack
Investments by Luciole Medical
Edit